Great news...
"MGH will perform additional analysis" -
What additional analysis it is referring to which apps algorithm and data analytics do not include ?
Why not add this additional analysis functionality in-built into the apps and use in clinical trials to ease FDA approvals ?
Would this tie-up delay or expedite fda approvals?
- Forums
- ASX - By Stock
- Ann: ResApp Announces Expanded Research Collaboration with MGH
Great news... "MGH will perform additional analysis" - What...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)